v3.26.1
Consolidated Balance Sheets - USD ($)
$ in Thousands
Dec. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents (Note 5) $ 1,339 $ 3,175
Restricted cash (Note 10) 495
Value added tax receivable, net (Note 7) 314
Prepaid expenses and other assets (Note 6) 107 364
Current assets held for sale (Note 4)
Total current assets 1,941 3,853
Property, plant and equipment, net (Note 8) 22 22
Investments (Note 5) 265 265
Right-of-use assets (Note 9) 9
Assets held for sale (Note 4) 667
Total assets 2,228 4,816
Current liabilities    
Accounts payable and other accrued liabilities (Note 10) 1,364 1,625
Other current liabilities (Note 11) 42
Current liabilities held for sale (Note 4) 1,970
Total current liabilities 1,364 3,637
Other long-term liabilities (Note 11)
Liabilities held for sale (Note 4) 3,281
Total liabilities 1,364 6,918
Commitments and contingencies (Note 16)
Equity (deficit) (Note 14)    
Common stock, $.01 par value, 100,000,000 shares authorized; 15,053,048 and 15,053,048 shares issued and outstanding, respectively 150 150
Additional paid-in capital 552,849 552,536
Accumulated deficit (552,135) (554,788)
Shareholders' equity (deficit) 864 (2,102)
Total liabilities and equity $ 2,228 $ 4,816